Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · IEX Real-Time Price · USD
1.76
-0.01 (-0.56%)
At close:
Mar 17, 2023, 4:00 PM
1.82
+0.06 (3.41%)
Pre-market:
Mar 20, 2023, 8:23 AM EDT
Stock Price Forecast
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CRDF stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '22 | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Financial Forecast
Revenue This Year
198.29K
from 386.00K
Decreased by
-48.63%
Revenue Next Year
68.00K
from 198.29K
Decreased by
-65.70%
EPS This Year
-1.05
from -0.89
EPS Next Year
-1.43
from -1.05
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 378.33K | 244.63K | 366.00K | 359.00K | 386.00K | 198.29K | 68.00K | 68.00K | 25.36M | 200.94M |
| Revenue Growth | -25.14% | -35.34% | 49.61% | -1.91% | 7.52% | -48.63% | -65.70% | - | 37,190.78% | 692.38% |
| EPS | -8.26 | -2.80 | -1.08 | -0.73 | -0.89 | -1.05 | -1.43 | -1.80 | -2.39 | - |
| EPS Growth | - | - | - | - | - | - | - | - | - | - |
| No. Analysts | - | - | - | - | - | 7 | 5 | 5 | 3 | - |
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 420,000 | 210,000 | 210,000 | 26.3M | 278.3M |
| Avg | 198,288 | 68,003 | 68,003 | 25.4M | 200.9M |
| Low | n/a | n/a | n/a | 24.2M | 126.4M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 8.8%
| 5.9%
| 208.8%
| 38,501.0%
| 997.2%
|
| Avg | -48.6%
| -65.7%
| - | 37,190.8%
| 692.4%
|
| Low | - | - | - | 35,530.6%
| 398.5%
|
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| High | -0.95 | -1.16 | -1.79 | -2.46 |
| Avg | -1.05 | -1.43 | -1.80 | -2.39 |
| Low | -1.22 | -1.81 | -1.78 | -2.29 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price target, rating and forecast data provided by Finnhub and sourced from Wall Street analysts and other sell-side and buy-side analysts and investors. Data disclaimer.